Form 4: Elanco Director Stacey Ma Reports Stock Unit Grants

Stacey Ma, a Director at Elanco Animal Health Inc., has reported the acquisition of deferred stock units and restricted stock units.

Summary

• Stacey Ma, a Director at Elanco Animal Health Inc. (ELAN), reported transactions on May 21, 2026.
• Ma acquired 4,678 deferred stock units as a pro-rated annual equity award.
• Ma also acquired 12,196 restricted stock units as an annual equity award.
• These awards were granted to non-employee members of the Issuer's Board of Directors.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine equity awards to a director and does not contain new financial information or strategic updates.

Positives

• Director Stacey Ma received equity awards, indicating continued incentive and alignment with the company's performance.
• The grants of deferred stock units and restricted stock units are part of Elanco's annual equity award program for non-employee directors.

Future Outlook

This filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that equity awards to directors are a common practice in the animal health industry to ensure alignment between leadership and shareholder interests.

Stakeholder Impact

• Shareholders: The equity awards to directors reinforce alignment between management and shareholder interests, a positive governance practice.

Key Dates

Keywords

Form 4, SEC Filing, Elanco Animal Health, ELAN, Stacey Ma, Director, Equity Award, Deferred Stock Units, Restricted Stock Units, Beneficial Ownership